Brain cancer originates in the brain and consists of brain cancer cells. But brain metastases from lung cancer occur when ... or during a procedure in which a small sample is taken with a needle.

Lung cancer arises in tissues of the lung, usually in the cells lining air passages. The two main types are small-cell ... William Jr. Metastatic spread of cancer to the brain has a devastating ...

renal cell carcinoma, sarcoma) and with 1–3 lesions (if not resectable or <1 cm) are best treated with stereotactic radiosurgery. The method of treatment of brain metastasis (BM) remains ...

Erratum: Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm ... previously treated, stable brain metastases ...

Recent cancer treatment breakthroughs include FDA approvals for zenocutuzumab and durvalumab, and sacituzumab tirumotecan gained breakthrough therapy status. In addition, sonodynamic therapy shows ...

The incidence of brain metastasis is high in patients with non-small-cell lung cancer. Available standard therapeutic options, such as whole-brain radiation therapy and systemic chemotherapy ...

Opens in a new tab or window HOUSTON -- Two-thirds of patients with PI3K-mutant brain metastases responded ... mesothelioma, and non-small cell lung cancer. Grossman reported findings from a ...

China’s drug regulator approved Alpha Biopharma Ltd.’s EGFR tyrosine kinase inhibitor (TKI), Zorifer (zorifertinib hydrochloride tablets; AZD-3759), as a first-line treatment for EGFR-mutated ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Optune Lua creates tumor-treating fields to disrupt cancer cell division, and it is used in conjunction with PD-1/PD-L1 inhibitors or docetaxel to treat metastatic non–small cell lung cancer ...

The investigational oral HER2-specific tyrosine kinase inhibitor would address an unmet need in non–small cell lung cancer.